title: A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
authors.affiliation: Respiratory Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Suri
authors.forename: C
authors.initials: C
authors.lastname: Wallis
authors.forename: A
authors.initials: A
authors.lastname: Bush
authors.forename: S
authors.initials: S
authors.lastname: Thompson
authors.forename: C
authors.initials: C
authors.lastname: Normand
authors.forename: M
authors.initials: M
authors.lastname: Flather
authors.forename: R
authors.initials: R
authors.lastname: Grieve
authors.forename: C
authors.initials: C
authors.lastname: Metcalfe
authors.forename: B
authors.initials: B
authors.lastname: Lees
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D018592:Cross-Over Studies; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000191:economics*; D003850:Deoxyribonuclease I / Q000008:administration & dosage* / Q000191:economics; D004334:Drug Administration Schedule; D017079:Exercise Tolerance / Q000187:drug effects; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D017048:Health Care Costs; D006801:Humans; D008297:Male; D017059:Models, Econometric; D009330:Nebulizers and Vaporizers; D010349:Patient Compliance; D011788:Quality of Life; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000191:economics; D012044:Regression Analysis; D012462:Saline Solution, Hypertonic / Q000191:economics / Q000627:therapeutic use*; D018709:Statistics, Nonparametric; D014797:Vital Capacity / Q000187:drug effects
chemical_list: D011994:Recombinant Proteins; D012462:Saline Solution, Hypertonic; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I